Aman Bhandari has extensive leadership experience in the corporate, academic and government sectors. Currently at Vertex Pharmaceuticals, he heads up the corporate data science, product and engineering team which builds solutions and applies advanced analytical techniques across the enterprise from HR to clinical trials. Prior to Vertex, Aman spent almost five years at Merck where he created their first formal data science team and built a global digital health and data science network, which provided access to startups and over 100 leading researchers across multiple disease areas and novel data sources. He helped pioneer the first time use of a wide variety of data + tech approaches at the company such as using natural language processing techniques for scientific research. He also was selected for the enterprise leadership program (top 2% of Merck).
Previously, Aman worked in the government in a variety of roles, including as a government research scientist at the Centers for Medicare and Medicaid Services and as a senior policy advisor at the White House for President Obama’s first two U.S. Chief Technology Officers. While in government he worked on national data and technology initiatives during the launch of Medicare Part D, the HITECH Act and the ACA. While in government he served on a various committees such as the White House Health IT Council and the CMS Genomics Subcommittee as well as supporting the launch of the Presidential Innovation Fellows program which brought entrepreneurs and technologists into government.
Currently, Aman is on the Digital Health Advisory Board for Boston Children’s Hospital. In the past he has been an advisor to the World Bank, USAID, Harvard, Cornell Tech, the Ashoka Foundation, Knight News Foundation and others. His work has been profiled in the Wall Street Journal, New York Times and other outlets. Aman holds a B.S in Biology from UC Irvine, an M.P.H in Epidemiology from the University of Minnesota and a Ph.D in Health Economics/Outcomes Research from UC Berkeley.